Expert consensus on maintenance treatment for metastatic colorectal cancer in China
文献类型：期刊论文
| 刊名 | CHINESE JOURNAL OF CANCER
 |
| 出版日期 | 2016 |
| 卷号 | 35 |
| 关键词 | BEVACIZUMAB CAPECITABINE THERAPY XELOX CHEMOTHERAPY OXALIPLATIN TRIAL STOP GO Metastatic colorectal cancer Maintenance therapy Consensus |
| ISSN号 | 1000-467X |
| 其他题名 | Expert consensus on maintenance treatment for metastatic colorectal cancer in China |
| 英文摘要 | The impact of maintenance therapy on progression-free survival and overall survival as well as quality of life of Chinese patients with metastatic colorectal cancer has long been under discussion. Recently, some phase III clinical trials have revealed that maintenance therapy can significantly prolong the progression-free survival while maintain an acceptable safety profile. Based on this evidence and common treatment practice in China, we now generated one Expert Consensus on Maintenance Treatment for Metastatic Colorectal Cancer in China to further specify the necessity of maintenance therapy, suitable candidates for such treatment, and appropriate regimens. |
| 语种 | 英语 |
| CSCD记录号 | CSCD:5629153 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/57555]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 推荐引用方式 GB/T 7714 | . Expert consensus on maintenance treatment for metastatic colorectal cancer in China[J]. CHINESE JOURNAL OF CANCER,2016,35. |
| APA | (2016).Expert consensus on maintenance treatment for metastatic colorectal cancer in China.CHINESE JOURNAL OF CANCER,35. |
| MLA | "Expert consensus on maintenance treatment for metastatic colorectal cancer in China".CHINESE JOURNAL OF CANCER 35(2016). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。